How Automating TLF Integration and Summarization in Clinical Trials Benefits Pharma Teams

May 08, 2026

Learn how automating the integration of tables, listings, and figures (TLFs) into CSRs and generating TLF summaries can benefit pharma teams.

image.png

Incorporating Tables, Listings, and Figures (TLFs) into Clinical Study Reports (CSRs) and writing accurate summaries of TLF data are time-intensive tasks that add to the workload of pharma teams, who are already managing multiple responsibilities in drug development. 

To address this, pharmaceutical companies can consider automating TLF integration and summarization to significantly reduce these inefficiencies, streamline medical writing workflows, and improve accuracy in regulatory documentation.

What is a TFL and How Does It Help Clinical Trials?

TLFs are structured outputs designed to summarize and present clinical trial data in a clear, standardized format. They play a central role in:

  • Analyzing clinical trial results

  • Preparing reports, including Clinical Study Reports (CSRs)

  • Supporting regulatory submissions

  • Answering queries from regulatory authorities

  • Guiding scientific publications

The Current Challenges of Manual TLF Integration and Summarization

Incorporating TLFs into CSRs and writing summaries manually is a complex and labor-intensive process. Medical writers must extract data from multiple TLF sources, align it with document templates, and craft accurate narrative descriptions. This leads to various challenges, including:

  • Variability in Data Handling and Presentation: Manual processes can lead to inconsistencies and discrepancies across outputs, making standardization difficult.

  • Time-Intensive Validation, Cleaning, and Formatting: Ensuring accuracy requires multiple rounds of review, consuming valuable time.

  • Increased Risk of Mistakes: Even minor errors in summarizing TLF data can cascade into larger issues, affecting downstream analyses and reporting.

  • Higher Workload for Statistical Programmers and Medical Writers: Repeated corrections and adjustments when source TLFs are updated slow down workflows and reduce productivity.

These challenges not only reduce efficiency but also delay the time to market for new drugs, which is critical in clinical research where every day counts. This is where automation using an AI platform for medical content authoring can be beneficial, streamlining the TLF integration and summarization process while improving accuracy.

Why Automate TLFs for Clinical Trial Research

Automating TLF integration and summarization through medical writing platforms offers numerous benefits for pharmaceutical organizations and pharma teams, as it can help with:

1. Efficiency and Time Savings

Medical writing platforms that automate TLF integration drastically reduce manual effort by rapidly incorporating existing TLFs into CSRs and generating accurate narrative summaries. This allows teams to spend less time on formatting, data alignment, and writing repetitive summary text, helping them consistently meet deadlines for Clinical Study Reports and other regulatory submissions.

2. Consistency and Standardization

Integrating a medical writing automation platform into the TLF workflow ensures uniform formatting and adherence to templates, enabling teams to deliver consistent data presentation and narrative style across the entire clinical trial lifecycle.

3. Data Integrity and Error Reduction

Manual TLF summarization is prone to human error, such as misreading values, omitting data points, or inconsistent phrasing. Medical writing platforms help mitigate this risk by generating summaries consistently from source TLFs, while team members focus on validating and reviewing outputs. By combining automated processing with human oversight, teams can improve data integrity and ensure reliable, high-quality results.

4. Resource Optimization

By automating repetitive integration and summarization tasks, teams can focus on higher-value activities such as data analysis, interpretation, and strategic decision-making, maximizing the impact of their expertise.

5. Regulatory Compliance

Leading medical writing platforms, like AuroraPrime, include built-in quality checks and precision benchmarks aligned with global standards such as 21 CFR Part 11, HIPAA, GDPR, ISO 9001, ISO 27001, and AICPA SOC 2 Type II. This ensures outputs are ready for submission to regulatory authorities with minimal risk of non-compliance.

image.png

Introducing AuroraPrime: Automation Solution for TLF Integration and Summarization

AuroraPrime supports medical writing automation by delivering AI-driven solutions that streamline the incorporation of TLFs into CSRs and the generation of accurate TLF summaries. It helps deliver consistent, high-quality narrative outputs through:

1. Multimodal Data Ingestion & Advanced Merge Table Algorithm for Complex TFLs

AuroraPrime can ingest existing TLFs directly into the authoring environment, reducing the need for manual copy-paste and formatting. It can even process fragmented or unusually formatted source tables and integrate them seamlessly into documents.

Some of the data it can process include:

  • Unstructured text from Word documents

  • Structured TFLs in RTF or Excel formats

  • Data from external systems like EDC and Pharmacovigilance (PV) platforms

2. Manual Identification of Row and Column Headers

Not all TLF data is perfectly standardized. But with AuroraPrime, teams can manually identify row and column headers, giving precise control over nuanced data structures. This ensures the AI understands context, producing summaries that reflect the true meaning of every data point.

3. AI-Powered TFL Summary Generation

AuroraPrime can automatically generate narrative summaries of TLF data using AI, dramatically reducing the manual writing effort traditionally required. Writers can provide custom prompts or examples, ensuring outputs follow the desired structure, style, and regulatory documentation requirements.

4. Batch Processing and Asynchronous Workflows

TLF summaries can also be generated and validated in batches without blocking other workflows. Medical writers can continue working on other sections while summary generation runs in the background, enabling efficient parallel workflows.

5. Efficient Updates and Validation

When source TLF data changes, AuroraPrime can automatically trigger revisions or create new draft summaries, reducing the need for manual intervention. Batch validation of TLF summaries allows comparison between summary text and the underlying data, highlighting discrepancies for quick and accurate correction.

Reduce Medical Writing Timelines with AuroraPrime

Automating TLFs integration and summarization has become essential for pharma teams aiming to stay competitive. By leveraging AI-driven TLF integration and summary generation with AuroraPrime, organizations can reduce manual effort, freeing up time and resources for high-value tasks such as data interpretation and strategic decision-making.

AuroraPrime’s next-generation platform transforms repetitive, manual processes into streamlined, AI-supported clinical reporting, ensuring faster, more accurate, and consistent outputs. If your organization is ready to explore smarter, faster and more intuitive clinical document authoring, now is the time to embrace smarter automation.

Discover how AuroraPrime can help your team deliver faster, more reliable clinical reporting today. For more insights into increasing efficiency of medical writing, check out how enterprises are architecting the global scale of GenAI in pharma R&D.